Stonebrook Private Inc. bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 727 shares of the semiconductor company's stock, valued at approximately $353,000.
A number of other large investors also recently modified their holdings of the stock. Norges Bank bought a new position in Synopsys in the 4th quarter valued at $583,608,000. Price T Rowe Associates Inc. MD lifted its stake in shares of Synopsys by 21.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company's stock valued at $2,864,933,000 after acquiring an additional 1,045,326 shares during the period. Capital Research Global Investors bought a new position in Synopsys in the fourth quarter valued at about $239,864,000. Raymond James Financial Inc. bought a new position in Synopsys in the fourth quarter valued at about $199,065,000. Finally, Ameriprise Financial Inc. increased its position in Synopsys by 26.2% in the fourth quarter. Ameriprise Financial Inc. now owns 1,888,181 shares of the semiconductor company's stock worth $916,441,000 after purchasing an additional 391,681 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity
In related news, insider Geus Aart De sold 15,705 shares of the firm's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the transaction, the insider now owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. This trade represents a 11.86% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $463.75, for a total value of $5,270,982.50. Following the completion of the transaction, the chief executive officer now owns 70,922 shares of the company's stock, valued at $32,890,077.50. The trade was a 13.81% decrease in their position. The disclosure for this sale can be found here. 0.62% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
SNPS has been the topic of a number of research reports. Mizuho cut their target price on shares of Synopsys from $650.00 to $600.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. KeyCorp upped their price objective on Synopsys from $555.00 to $575.00 and gave the company an "overweight" rating in a report on Tuesday. Bank of America reduced their target price on Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a report on Wednesday, April 16th. Piper Sandler decreased their target price on Synopsys from $655.00 to $653.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Finally, Wells Fargo & Company cut their price target on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $614.86.
Check Out Our Latest Analysis on Synopsys
Synopsys Price Performance
SNPS stock traded down $0.40 during trading hours on Tuesday, reaching $515.61. 740,736 shares of the stock were exchanged, compared to its average volume of 1,107,856. The firm's 50-day moving average is $447.85 and its 200-day moving average is $489.13. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $624.80. The company has a market cap of $79.72 billion, a price-to-earnings ratio of 35.51, a PEG ratio of 3.23 and a beta of 1.16.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.